openPR Logo
Press release

Antiviral Drugs Market: Growth of Medical Research in Emerging Asia Pacific Countries Increases Demand

07-06-2018 11:14 AM CET | Health & Medicine

Press release from: TMR - Research Reports

Antiviral Drugs Market: Growth of Medical Research in Emerging

Global Antiviral Drugs Market: Snapshot

The global antiviral drugs market is foreseen to receive a strong push in its growth due to swelling prevalence of viral infections. It could also be substantially contributed to as chronic infections that call for long-term treatment, including hepatitis B and HIV/AIDS, spread extensively across the globe. Market growth is prognosticated to gain strength with increasing cases of new viral infections and diseases. In order to counter the spread of viral infections, development of various therapies and drugs has been considerably focused upon as drugmakers give more significance to research and development.

Request Sample of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=21083

Expected to post a 6.4% CAGR for the forecast tenure 2016-2024, the global antiviral drugs market could rake in an US$82.9 bn by the completion of the final forecast year.

HIV to Score Big with High Demand for New Drugs to Contain Spread of Infection

On the basis of disease indication, the world antiviral drugs market has been segregated into four segments, viz. respiratory viral infection, HIV infection, hepatitis viral infection, and other types of infection. Although antiviral drugs are consistently used in the treatment of these infections, HIV is foretold to achieve stronger growth in the market for the next few years. This could be on account of the dangerous increase in the incidence of HIV infection. Demand in the HIV infection market for antiviral drugs is projected to stay higher than that in other disease indication markets.

Read Report Overview: https://www.transparencymarketresearch.com/antiviral-drugs-market.html

Innovation in the world antiviral drugs market and invention of new drugs could be attributed for improving the lifespan of HIV patients. Demand for new HIV drugs is forecasted to grow more in the near term as developing countries continue to make affordable drugs available to the public and promising reimbursement policies to impress patients.

In terms of type of product, the world antiviral drugs market has been classified into two main segments, i.e. generic and branded drugs. By distribution channel, the report has divided the market into online pharmacy, retail pharmacy store, and hospital pharmacy store.

Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=21083

North America to Sit Atop Growth Using Revenue Earned from Expensive Novel Drugs

Having collected a colossal percentage of share in the recent past, North America could well be a candidate for securing the lead in the international antiviral drugs market. Market growth in this region is envisaged to gain momentum with high cost of new drugs complementing high purchasing power and disposable income of patients. The region could be trailed by Europe as consumers show high preference for novel drugs and the number of patients taking antiretroviral treatments surges. Other factors that could help Europe to take the second position are continuous introduction of new drugs and better diagnostic facilities.

Asia Pacific is also predicted to offer rewarding prospects in the international antiviral drugs market because of quick spread of influenza and other infectious viral diseases and increasing penetration of drugs for Zika, Ebola, and other highly infectious viruses. Other regions such as the Middle East and Africa could tread upon the heels of Asia Pacific.

Some of the top companies functioning in the international antiviral drugs market are GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co. Inc., Mylan N.V., and Teva Pharmaceutical Industries Ltd.

About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antiviral Drugs Market: Growth of Medical Research in Emerging Asia Pacific Countries Increases Demand here

News-ID: 1113326 • Views:

More Releases from TMR - Research Reports

Visualization and 3D Rendering Software Market: On-Premise Deployment Presently …
The global market for visualization and 3D rendering features a largely consolidated vendor landscape, with the leading three vendors accounting for a nearly 80% of the overall revenue generated in the market in 2016, observes Transparency Market Research in a recent report. These three vendors, namely Autodesk Inc., Dassault Systems, and NVIDIA Corporation, have strengthened their positions in the market with the help of cost competitive pricing, continuous introduction of
Digital Door Lock Systems Market: Enhanced Security Requirements to Propel the D …
According to a new market report published by Transparency Market Research titled “Digital Door Lock Systems Market–Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026,” the global digital door lock systems market was valued at US$ 1,059.5 Mn in 2017 and is expected to expand at a CAGR of 30.25% from 2018 to 2026, reaching US$ 14,877.6 Mn by the end of the forecast period. digital door lock systems market
Transportation Management System Market: Advance Technologies in All the Sectors …
A transportation management system (TMS) refers to a subset of supply chain management and is centered mostly on logistics and transportation. The augmented use of cloud computing technologies for managing supply chain activities is one of the significant and major trends that have been prevailing in the world market for transportation management systems. Cloud-based deployments, in general, need less configuration and customization. These two factors are triggering down the cost
Energy Recovery Ventilators Market: Rising Awareness of Importance of Indoor Air …
Characterized by the presence of a handful of dominant players, namely United Technologies Corp., LG Electronics, Daikin Industries Ltd., Fujitsu Ltd., and Munters Corp., the global energy recovery ventilators market features intense competition, reveals Transparency Market Research (TMR) in a new report. Going forward, the rising number of players seeking entry will further intensify competition in the market. Expansion of product portfolio which has been the focus of established companies to

All 5 Releases


More Releases for HIV

HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Introduction to Human Immunodeficiency Virus (HIV) Vaccines 1.1 Overview 1.2 Antiquity of HIV Vaccine Need for the Development of HIV Vaccine Primer of HIV inside the Body 3.1 Inclusion of HIV Virus into the System 3.2 Interaction of HIV with Host 3.3 Eradication of HIV Virus HIV Vaccine Development Process 4.1 Introduction
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus. Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral